Author details

Full Name

SangYun Kim

Affiliation

ORCID

Career Start Year

2002

Papers

209

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37563770	Transcriptional risk scores in Alzheimer's disease: From pathology to cognition.	Alzheimers Dement	2024
36282189	The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis.	Int J Stroke	2023
37961387	miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.	Res Sq	2023
37550761	Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.		2023
37200243	Increased oligomeric TDP-43 in the plasma of Korean frontotemporal dementia patients with semantic dementia.		2023
37179690	Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure.		2023
37032921	Ensemble graph neural network model for classification of major depressive disorder using whole-brain functional connectivity.		2023
36941727	Blood pressure and dementia risk by physical frailty in the elderly: a nationwide cohort study.		2023
36897291	Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific.	Ann Neurol	2023
36759256	Pathogenic Role of RAGE in Tau Transmission and Memory Deficits.		2023
36745453	Changes in Alcohol Consumption and Risk of Dementia in a Nationwide Cohort in South Korea.		2023
36642501	Heritability of cognitive abilities and regional brain structures in middle-aged to elderly East Asians.	Cereb Cortex	2023
36215961	The Effect of Hearing Loss on Cognitive Function in Subjective Cognitive Decline.	Dementia and Geriatric Cognitive Disorders	2022
36071894	Predicting progression to dementia with "comprehensive visual rating scale" and machine learning algorithms.	Frontiers in Neurology	2022
35804462	Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.	Alzheimer's Research and Therapy	2022
35786657	Implications of Liver Enzymes in the Pathogenesis of Alzheimer's Disease.	J Alzheimers Dis	2022
35769874	Immunity gene <i>IFITM3</i> variant: Relation to cognition and Alzheimer's disease pathology.	Alzheimers Dement (Amst)	2022
35756922	Whole Exome Sequencing Reveals a Novel APOE Mutation in a Patient With Sporadic Early-Onset Alzheimer's Disease.	Frontiers in Neurology	2022
35743503	Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment.	Journal of Clinical Medicine	2022
35694927	Subclinical Hypothyroidism and Cognitive Impairment.	Journal of Alzheimer's Disease	2022
35653621	Neuropsychological test using machine learning for cognitive impairment screening.	Applied neuropsychology. Adult	2022
35547155	Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia.	International Journal of Alzheimer's Disease	2022
35456351	Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism.	Journal of Clinical Medicine	2022
35381591	Subtle Cognitive Deficits Are Associated with Amyloid-Î² Positivity, but Not Severity of Self-Reported Decline: Results from the CoSCo Study.	Dementia and Geriatric Cognitive Disorders	2022
35023070	A Creutzfeldt-Jakob disease patient with V180I mutation survived for 16.5Â years after diagnosis.	Acta Neurologica Belgica	2022
36733444	Integration of amyloid-Î² oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis.		2022
36657424	Subjective Memory Complaints and Their Relationship with the Objective Cognitive Performance of Stroke Patients.		2022
36587215	Alpha-synuclein: a pathological factor with AÎ² and tau and biomarker in Alzheimer's disease.		2022
36447739	Genetic Screening in Korean Patients with Frontotemporal Dementia Syndrome.	Journal of Alzheimer's Disease Reports	2022
36407290	Electroencephalography for Early Detection of Alzheimer's Disease in Subjective Cognitive Decline.		2022
36407288	Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study.		2022
36362122	PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer's Disease.	International Journal of Molecular Sciences	2022
36344984	Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-Î² oligomerization data.	BMC Medical Informatics and Decision Making	2022
33827446	Caregiving, care burden and awareness of caregivers and patients with dementia in Asian locations: a secondary analysis.	BMC Geriatrics	2021
33654168	Misplacement of something inside the refrigerator is not a sign of dementia, but a probable symptom of attention deficit due to depression.	Scientific Reports	2021
33652290	Increased plasma levels of chitinase 3-like 1 (CHI3L1) protein in patients with idiopathic normal-pressure hydrocephalus.	Journal of the Neurological Sciences	2021
33490361	Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research.	Alzheimers Dement (N Y)	2021
33422673	Endogenous AÎ² peptide promote AÎ² oligomerization tendency of spiked synthetic AÎ² in Alzheimer's disease plasma.	Molecular and Cellular Neurosciences	2021
33402198	Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.	Alzheimer's Research and Therapy	2021
33397486	Differences between memoryÂ encoding and retrieval failure in mild cognitive impairment: results from quantitative electroencephalography and magnetic resonance volumetry.	Alzheimer's Research and Therapy	2021
33352000	Strategies for the use of Ginkgo biloba extract, EGb 761 , in the treatment and management of mild cognitive impairment in Asia: Expert consensus.	CNS Neuroscience and Therapeutics	2021
34785643	A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages.	Transl Psychiatry	2021
34732252	Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-Î² deposition in Alzheimer's disease.	Alzheimers Res Ther	2021
34679393	A Pathogenic Presenilin-1 Val96Phe Mutation from a Malaysian Family.	Brain Sciences	2021
34518459	Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial.	Dementia and Geriatric Cognitive Disorders	2021
34465370	Predictability of polygenic risk score for progression to dementia and its interaction with APOE Îµ4 in mild cognitive impairment.	Transl Neurodegener	2021
34401068	Association of 25-hydroxyvitamin D status with brain volume changes.	Food Science and Nutrition	2021
34315986	Association between statin use and Alzheimer's disease with dose response relationship.	Scientific Reports	2021
34311775	Plasma amyloid-Î² oligomerization assay as a pre-screening test for amyloid status.	Alzheimer's Research and Therapy	2021
34305578	Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease.	Frontiers in Aging Neuroscience	2021